Search hospitals > Nevada > Reno
Sierra Eye Associates
Claim this profileReno, Nevada 89502
Global Leader in Age-Related Macular Degeneration
Global Leader in Macular Degeneration
Conducts research for Diabetic Macular Edema
Conducts research for Retinal Disease
Conducts research for Retinal Degeneration
83 reported clinical trials
2 medical researchers
Summary
Sierra Eye Associates is a medical facility located in Reno, Nevada. This center is recognized for care of Age-Related Macular Degeneration, Macular Degeneration, Diabetic Macular Edema, Retinal Disease, Retinal Degeneration and other specialties. Sierra Eye Associates is involved with conducting 83 clinical trials across 30 conditions. There are 2 research doctors associated with this hospital, such as Arshad Khanani, MD and Reno Site PI.Area of expertise
1Age-Related Macular Degeneration
Global LeaderStage I
CFI positive
Stage II
2Macular Degeneration
Global LeaderStage I
Stage II
CFI positive
Top PIs
Arshad Khanani, MDSierra Eye Associates2 years of reported clinical research
Studies Age-Related Macular Degeneration
Studies Diabetic Retinopathy
5 reported clinical trials
7 drugs studied
Reno Site PIReno Location5 years of reported clinical research
Studies Diabetic Retinopathy
Studies Diabetic Macular Edema
1 reported clinical trial
1 drug studied
Clinical Trials running at Sierra Eye Associates
Age-Related Macular Degeneration
Macular Degeneration
Choroidal Neovascularization
Diabetic Macular Edema
Retinal Degeneration
Retinal Disease
None
Choroidal neovascularization
Wet AMD
Cystoid Macular Edema
RGX-314 Gene Therapy
for Age-Related Macular Degeneration
This trial is testing a new one-time gene therapy called RGX-314 for patients with wet AMD. The goal is to reduce the need for regular treatments by helping the eye produce its own protective proteins. This could make treatment easier and more effective for patients.
Recruiting2 awards Phase 32 criteria
4D-150 + EYLEA
for Age-Related Macular Degeneration
A Phase 3, Randomized, Double-Masked, Active-Controlled Trial in Adults with Macular Neovascularization Secondary to Age-Related Macular Degeneration
Recruiting2 awards Phase 34 criteria
PDS Implant with Ranibizumab
for Age-Related Macular Degeneration
This study will evaluate the long-term safety and tolerability of the Port Delivery System with ranibizumab (PDS) (100 mg/mL) in participants with neovascular age-related macular degeneration (nAMD) who have either completed Phase II Study GX28228 (Ladder), Phase III Study GR40548 (Archway), Phase IIIb Study WR42221 (Velodrome), or completed Week 24 visit in Study WR42221 but were not eligible to be randomized in WR42221.
Recruiting2 awards Phase 33 criteria
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at Sierra Eye Associates?
Sierra Eye Associates is a medical facility located in Reno, Nevada. This center is recognized for care of Age-Related Macular Degeneration, Macular Degeneration, Diabetic Macular Edema, Retinal Disease, Retinal Degeneration and other specialties. Sierra Eye Associates is involved with conducting 83 clinical trials across 30 conditions. There are 2 research doctors associated with this hospital, such as Arshad Khanani, MD and Reno Site PI.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.